Literature DB >> 12031736

Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucose-lowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose).

Alawi A Alsheikh-Ali1, Heather M Abourjaily, Richard H Karas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12031736     DOI: 10.1016/s0002-9149(02)02334-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  4 in total

Review 1.  Pharmacokinetic interactions with thiazolidinediones.

Authors:  André J Scheen
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

2.  A computerized system for detecting signals due to drug-drug interactions in spontaneous reporting systems.

Authors:  Yifeng Qian; Xiaofei Ye; Wenmin Du; Jingtian Ren; Yalin Sun; Hainan Wang; Baozhang Luo; Qingbin Gao; Meijing Wu; Jia He
Journal:  Br J Clin Pharmacol       Date:  2010-01       Impact factor: 4.335

Review 3.  Drug Interactions of Clinical Importance with Antihyperglycaemic Agents : An Update.

Authors:  André J Scheen
Journal:  Drug Saf       Date:  2005-07       Impact factor: 5.606

Review 4.  The development of combination drugs for atherosclerosis.

Authors:  Donald M Black
Journal:  Curr Atheroscler Rep       Date:  2003-01       Impact factor: 5.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.